The effect of CA1 dopaminergic system in harmaline-induced amnesia

Neuroscience

Volumn 285, Issue , 2015, Pages 47-59

  Nasehi, M ^a,c   Ketabchi, M ^b   Khakpai, F ^c   Zarrindast, M R ^a,c,d,e,f  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

CA1; Dopamine; Harmaline; Passive avoidance memory; Step down

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HARMALINE; QUINPIROLE; SULPIRIDE; BENZAZEPINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; MONOAMINE OXIDASE INHIBITOR;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HIPPOCAMPAL CA1 REGION; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DRUG EFFECTS; MEMORY; METABOLISM; PHYSIOLOGY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AMNESIA; ANIMALS; AVOIDANCE LEARNING; BENZAZEPINES; CA1 REGION, HIPPOCAMPAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HARMALINE; MALE; MEMORY; MICE; MONOAMINE OXIDASE INHIBITORS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 84913554911     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.11.012     Document Type: Article

References (79)

1. Ajdary S., Ghamilouie M.M., Alimohammadian M.H., Riazi-Rad F., Pakzad S.R. Toll-like receptor 4 polymorphisms predispose to cutaneous leishmaniasis. Microbes Infect 2011, 13:226-231.
2. Anderson N.J., Tyacke R.J., Husbands S.M., Nutt D.J., Hudson A.L., Robinson E.S. In vitro and ex vivo distribution of [3H]harmane, an endogenous beta-carboline, in rat brain. Neuropharmacology 2006, 50:269-276.
3. Ataee R., Ajdary S., Zarrindast M., Rezayat M., Hayatbakhsh M.R. Anti-mitogenic and apoptotic effects of 5-HT1B receptor antagonist on HT29 colorectal cancer cell line. J Cancer Res Clin Oncol 2010, 136:1461-1469.
4. Baum S.S., Hill R., Rommelspacher H. Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. Eur J Pharmacol 1996, 314:75-82.
5. Bethus I., Tse D., Morris R.G. Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptor-dependent paired associates. J Neurosci 2010, 30:1610-1618.
6. Bonnet U., Scherbaum N., Wiemann M. The endogenous alkaloid harmane: acidifying and activity-reducing effects on hippocampal neurons in vitro. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:362-367.
7. Bressan R.A., Crippa J.A. The role of dopamine in reward and pleasure behaviour - review of data from preclinical research. Acta Psychiatr Scand Suppl 2005, 14-21.
8. Burgess N., Maguire E.A., O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35:625-641.
9. Chagniel L., Robitaille C., Lacharite-Mueller C., Bureau G., Cyr M. Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control. Behav. Brain Res. 2012, 228:9-15.
10. Daumas S., Halley H., Frances B., Lassalle J.M. Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn Mem 2005, 12:375-382.
11. de Lima M.N., Presti-Torres J., Dornelles A., Scalco F.S., Roesler R., Garcia V.A., Schroder N. Modulatory influence of dopamine receptors on consolidation of object recognition memory. Neurobiol Learn Mem 2011, 95:305-310.
12. Faerber L., Drechsler S., Ladenburger S., Gschaidmeier H., Fischer W. The neuronal 5-HT3 receptor network after 20years of research - evolving concepts in management of pain and inflammation. Eur J Pharmacol 2007, 560:1-8.
13. Ferreira T.B., Kasahara T.M., Barros P.O., Vieira M.M., Bittencourt V.C., Hygino J., Andrade R.M., Linhares U.C., Andrade A.F., Bento C.A. Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder. J Neuroimmunol 2011, 238:58-66.
14. Feuerstein T.J. Presynaptic receptors for dopamine, histamine, and serotonin. Handb Exp Pharmacol 2008, 289-338.
15. Frostholm A., Evans J.E., Cummings S.L., Rotter A. Harmaline-induced changes in gamma aminobutyric acid(A) receptor subunit mRNA expression in murine olivocerebellar nuclei. Brain Res Mol Brain Res 2000, 85:200-208.
16. Gangarossa G., Longueville S., De Bundel D., Perroy J., Hervé D., Girault J.A., Valjent E. Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus. Hippocampus 2012, 22:2199-2207.
17. Garelick M.G., Storm D.R. The relationship between memory retrieval and memory extinction. Proc Natl Acad Sci USA 2005, 102:9091-9092.
18. Glennon R.A., Dukat M., Grella B., Hong S., Costantino L., Teitler M., Smith C., Egan C., Davis K., Mattson M.V. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend 2000, 60:121-132.
19. Glick S.D., Kuehne M.E., Maisonneuve I.M., Bandarage U.K., Molinari H.H. 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res 1996, 719:29-35.
20. Glick S.D., Kuehne M.E., Raucci J., Wilson T.E., Larson D., Keller R.W., Carlson J.N. Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum. Brain Res 1994, 657:14-22.
21. Gonzalez-Burgos I., Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog Brain Res 2008, 172:603-623.
22. Granado N., Ortiz O., Suarez L.M., Martin E.D., Cena V., Solis J.M., Moratalla R. D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus. Cereb Cortex 2008, 18:1-12.
23. Hale M.W., Crowe S.F. Facilitation and disruption of memory for the passive avoidance task in the day-old chick using dopamine D1 receptor compounds. Behav Pharmacol 2003, 14:525-532.
24. Hamsa T.P., Kuttan G. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Eur J Pharmacol 2010, 649:64-73.
25. Hartman R.E., Lee J.M., Zipfel G.J., Wozniak D.F. Characterizing learning deficits and hippocampal neuron loss following transient global cerebral ischemia in rats. Brain Res 2005, 1043:48-56.
26. Harvey J.A. Role of the serotonin 5-HT(2A) receptor in learning. Learn Mem 2003, 10:355-362.
27. Herraiz T., Chaparro C. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 2005, 326:378-386.
28. Huang Y.Y., Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 1995, 92:2446-2450.
29. Izquierdo I., Medina J.H., Izquierdo L.A., Barros D.M., de Souza M.M., Mello Souza T. Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiol Learn Mem 1998, 69:219-224.
30. Jimenez J., Riveron-Negrete L., Abdullaev F., Espinosa-Aguirre J., Rodriguez-Arnaiz R. Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro. Exp Toxicol Pathol 2008, 60:381-389.
31. Kandel D., Weeks J.D. Simultaneous bunching and debunching of surface steps: theory and relation to experiments. Phys Rev Lett 1995, 74:3632-3635.
32. Khakpai F., Nasehi M., Haeri-Rohani A., Eidi A., Zarrindast M.R. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum. Behav Brain Res 2012, 231:1-10.
33. Khakpai F., Nasehi M., Haeri-Rohani A., Zarrindast M.R. Septo-hippocampo-septal loop and memory formation. Basic Clin Neurosci 2013, 4:5-23.
34. Kim J.S., Hassler R., Kurokawa M., Bak I.J. Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin, and dopamine. Exp Neurol 1970, 29:189-200.
35. Kleven M.S., Woolverton W.L. Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 1993, 31:149-158.
36. Lemon N., Manahan-Vaughan D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J Neurosci 2006, 26:7723-7729.
37. Liu Q.S., Pu L., Poo M.M. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 2005, 437:1027-1031.
38. Martin L., Martin M.A., del Castillo B. Changes in acid-base equilibria of harmine and harmane inclusion complexes with cyclodextrins. Biomed Chromatogr 1997, 11:87-88.
39. McGaugh J.L. Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Res Bull 1989, 23:339-345.
40. McGaugh J.L. Memory - a century of consolidation. Science 2000, 287:248-251.
41. Meignin C., Hilber P., Caston J. Influence of stimulation of the olivocerebellar pathway by harmaline on spatial learning in the rat. Brain Res 1999, 824:277-283.
42. Meller E., Bohmaker K., Goldstein M., Basham D.A. Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. Eur J Pharmacol 1993, 249:R5-R6.
43. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
44. Moura D.J., Rorig C., Vieira D.L., Henriques J.A., Roesler R., Saffi J., Boeira J.M. Effects of beta-carboline alkaloids on the object recognition task in mice. Life Sci 2006, 79:2099-2104.
45. Munoz M.A., Guardado P., Galan M., Carmona C., Balon M. A spectroscopic study of the molecular interactions of harmane with pyrimidine and other diazines. Biophys Chem 2000, 83:101-109.
46. Nasehi M., Mashaghi E., Khakpai F., Zarrindast M.R. Suggesting a possible role of CA1 histaminergic system in harmane-induced amnesia. Neurosci Lett 2013, 556:5-9.
47. Nasehi M., Piri M., Nouri M., Farzin D., Nayer-Nouri T., Zarrindast M.R. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol 2010, 634:77-83.
48. Nasehi M., Sharifi S., Zarrindast M.R. Involvement of the cholinergic system of CA1 on harmane-induced amnesia in the step-down passive avoidance test. J Psychopharmacol 2012, 26:1151-1161.
49. Nenaah G. Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects. Fitoterapia 2010, 81:779-782.
50. O'Carroll C.M., Martin S.J., Sandin J., Frenguelli B., Morris R.G. Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory. Learn Mem 2006, 13:760-769.
51. Otmakhova N.A., Lisman J.E. D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J Neurosci 1996, 16:7478-7486.
52. Otmakhova N.A., Lisman J.E. Dopamine, serotonin, and noradrenaline strongly inhibit the direct perforant path-CA1 synaptic input, but have little effect on the Schaffer collateral input. Ann N Y Acad Sci 2000, 911:462-464.
53. Palmery M., Leone M.G., Pimpinella G., Silvestrini B. Facilitating effect of harmaline on the aortic response to dopamine. Pharmacol Res 1992, 25(suppl. 1):7-8.
54. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press. 2nd ed.
55. Rezayof A., Motevasseli T., Rassouli Y., Zarrindast M.R. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci 2007, 80:285-292.
56. Richtand N.M., Woods S.C., Berger P., Strakowski S.M. D3 dopamine receptor, behavioral sensitization, and psychosis. Neurosci Biobehav Rev 2001, 25:427-443.
57. Riedel G., Micheau J. Function of the hippocampus in memory formation: desperately seeking resolution. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:835-853.
58. Rommelspacher H., Strauss S., Lindemann J. Excretion of tetrahydroharmane and harmane into the urine of man and rat after a load with ethanol. FEBS Lett 1980, 109:209-212.
59. Rook Y., Schmidtke K.U., Gaube F., Schepmann D., Wunsch B., Heilmann J., Lehmann J., Winckler T. Bivalent β-carbolines as potential multitarget anti-Alzheimer agents. J Med Chem 2010, 53:3611-3617.
60. Rossato J.I., Bevilaqua L.R., Izquierdo I., Medina J.H., Cammarota M. Dopamine controls persistence of long-term memory storage. Science 2009, 325:1017-1020.
61. Rozas C., Loyola S., Ugarte G., Zeise M.L., Reyes-Parada M., Pancetti F., Rojas P., Morales B. Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism. Eur Neuropsychopharmacol 2012, 22:584-595.
62. Ruiz-Durantez E., Ruiz-Ortega J.A., Pineda J., Ugedo L. Stimulatory effect of harmane and other beta-carbolines on locus coeruleus neurons in anaesthetized rats. Neurosci Lett 2001, 308:197-200.
63. Seamans J.K., Floresco S.B., Phillips A.G. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 1998, 18:1613-1621.
64. Splettstoesser F., Bonnet U., Wiemann M., Bingmann D., Busselberg D. Modulation of voltage-gated channel currents by harmaline and harmane. Br J Pharmacol 2005, 144:52-58.
65. Swanson-Park J.L., Coussens C.M., Mason-Parker S.E., Raymond C.R., Hargreaves E.L., Dragunow M., Cohen A.S., Abraham W.C. A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience 1999, 92:485-497.
66. Talhout R., Opperhuizen A., Amsterdam J.V. Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol 2007, 17:627-636.
67. Tang L., Todd R.D., O'Malley K.L. Dopamine, D2 and D3 receptors inhibit dopamine release. J Pharmacol Exp Ther 1994, 270:475-479.
68. Tarantino I.S., Sharp R.F., Geyer M.A., Meves J.M., Young J.W. Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behav Brain Res 2011, 219:181-188.
69. Thierry A.M., Gioanni Y., Degenetais E., Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000, 10:411-419.
70. Touiki K., Rat P., Molimard R., Chait A., de Beaurepaire R. Harmane inhibits serotonergic dorsal raphe neurons in the rat. Psychopharmacology 2005, 182:562-569.
71. Umegaki H., Munoz J., Meyer R.C., Spangler E.L., Yoshimura J., Ikari H., Iguchi A., Ingram D.K. Involvement of dopamine D(2) receptors in complex maze learning and acetylcholine release in ventral hippocampus of rats. Neuroscience 2001, 103:27-33.
72. Vallone D., Roberto P., Emiliana B. Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000, 24:125-132.
73. Vanderschuren L.J., Wardeh G., De Vries T.J., Mulder A.H., Schoffelmeer A.N. Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleus accumbens noradrenaline release. J Neurosci 1999, 19:4123-4131.
74. Venault P., Chapouthier G. From the behavioral pharmacology of beta-carbolines to seizures, anxiety, and memory. ScientificWorldJournal 2007, 7:204-223.
75. Whishaw I.Q. Place learning in hippocampal rats and the path integration hypothesis. Neurosci Biobehav Rev 1998, 22:209-220.
76. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 2004, 5:483-494.
77. Yang M.L., Kuo P.C., Hwang T.L., Chiou W.F., Qian K., Lai C.Y., Lee K.H., Wu T.S. Synthesis, in vitro anti-inflammatory and cytotoxic evaluation, and mechanism of action studies of 1-benzoyl-beta-carboline and 1-benzoyl-3-carboxy-beta-carboline derivatives. Bioorg Med Chem 2011, 19:1674-1682.
78. Zarrindast M.R., Ardjmand A., Ahmadi S., Rezayof A. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus. Behav Brain Res 2012, 229:68-73.
79. Zarrindast M.R., Dorrani M., Lachinani R., Rezayof A. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice. Neurosci Res 2010, 67:25-32.